The massive pharmaceuticals distributor said it is offering employees severance. It plans to begin layoffs on March 3.

Wednesday, McKesson Corporation (NYSE ... including higher volumes from specialty products, retail national account customers, and GLP-1 medications (used to treat diabetes and obesity), partially ...

McKesson Corp. closed $61.27 short of its 52-week high ($637.51), which the company reached on August 2nd.

McKesson (MCK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

McKesson , which belongs to the Zacks Medical - Dental Supplies industry, posted revenues of $93.65 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 4.66%.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

In a report released today, Allen Lutz from Bank of America Securities maintained a Buy rating on McKesson (MCK – Research Report). The ...

McKesson Corporation MCK witnessed strong ... along with other healthcare-related products, on a global basis. The second segment offers enterprise-wide clinical, patient care, financial, supply ...

Mizuho Securities analyst Ann Hynes maintained a Hold rating on McKesson (MCK – Research Report) on December 3. The company’s shares opened ...